|
|
Streptococcal infection and Cellulitis
Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma.
Haematologica
Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b.
Haematologica
Polyclonal proliferation of plasma cells associated with marked hypergammaglobulinemia in an elderly patient.
International journal of hematology
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
Annals of hematology
The rational designed antagonist derived from the complex structure of interleukin-6 and its receptor affectively blocking interleukin-6 might be a promising treatment in multiple myeloma.
Biochimie
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research
Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis.
Laboratory investigation; a journal of technical methods and pathology
Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
Mediators of inflammation
Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma.
Leukemia & lymphoma
Antimyeloma activity of heat shock protein-90 inhibition.
Blood
Mitogenic signals initiated via interleukin-6 receptor complexes in cooperation with other transmembrane molecules in myelomas.
Journal of clinical and experimental hematopathology : JCEH
Humanized anti-interleukin-6 receptor monoclonal antibody induced apoptosis of fresh and cloned human myeloma cells in vitro.
Leukemia research
R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways.
Molecular cancer therapeutics
Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotherapy: a phase I/II trial.
Leukemia & lymphoma
Expression and function of CD28 on Epstein-Barr virus-positive B cell lines and AIDS-associated non-Hodgkin's lymphoma cell lines.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Atlizumab: anti-IL-6 receptor antibody-Chugai, anti-interleukin-6 receptor antibody-Chugai, MRA-Chugai.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
Blood
Expression of interleukin-11 receptor in CD38-positive cells from patients with multiple myeloma.
Leukemia & lymphoma
Characterization of anti-mouse interleukin-6 receptor antibody.
Immunology letters
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma.
Haematologica
Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b.
Haematologica
Polyclonal proliferation of plasma cells associated with marked hypergammaglobulinemia in an elderly patient.
International journal of hematology
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
Annals of hematology
The rational designed antagonist derived from the complex structure of interleukin-6 and its receptor affectively blocking interleukin-6 might be a promising treatment in multiple myeloma.
Biochimie
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research
Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis.
Laboratory investigation; a journal of technical methods and pathology
Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
Mediators of inflammation
Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma.
Leukemia & lymphoma
Antimyeloma activity of heat shock protein-90 inhibition.
Blood
Mitogenic signals initiated via interleukin-6 receptor complexes in cooperation with other transmembrane molecules in myelomas.
Journal of clinical and experimental hematopathology : JCEH
Humanized anti-interleukin-6 receptor monoclonal antibody induced apoptosis of fresh and cloned human myeloma cells in vitro.
Leukemia research
R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways.
Molecular cancer therapeutics
Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotherapy: a phase I/II trial.
Leukemia & lymphoma
Expression and function of CD28 on Epstein-Barr virus-positive B cell lines and AIDS-associated non-Hodgkin's lymphoma cell lines.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Atlizumab: anti-IL-6 receptor antibody-Chugai, anti-interleukin-6 receptor antibody-Chugai, MRA-Chugai.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
Blood
Expression of interleukin-11 receptor in CD38-positive cells from patients with multiple myeloma.
Leukemia & lymphoma
Characterization of anti-mouse interleukin-6 receptor antibody.
Immunology letters
Get breaking news about nutritional cures, dangerous chemicals, superfoods and more.
Subscribe to the FREE Natural News email newsletter. Your privacy is protected.
See more studies on Streptococcal infection and...
How is this determined?
The order of these related concepts is determined by a statistical analysis of the scientific literature. Highest-frequency concepts appear first.
|
Fever 451 Hemolytic 413 blood 404 skin 368 antibiotics 301 Infectious 274 Rheumatic fever 267 Sepsis 256 Inflammatory 254 heart 190 Toxic shock syndrome 179 Group B streptococcal infection 169 Antimicrobial 158 Meningitis 155 Group A streptococcal infection 147 arthritis 145 Death 132 Endocarditis 128 Necrotizing Fasciitis 124 Pneumonia 108 Tonsillitis 86 Rheumatic heart 86 heart disease 84 lead 84 pain 83 Cellulitis 81 |
Chorea 76 Psoriasis 67 diabetes 60 Toxins 59 pregnancy 53 Clindamycin 52 Varicella 52 hepatitis 45 Septicemia 42 renal failure 41 cysteine 41 vaccines 40 Scarlet fever 37 cancer 36 Impetigo 33 Guttate psoriasis 33 hypertension 32 Milk 31 tonsils 26 Tourette syndrome 23 Uveitis 20 muscles 13 Proliferative 13 Nervous system 13 Neutropenia 13 |
